Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Ce mark symbols : Bsx save search
At 4.37% CAGR, Medical Electrodes Market Size to hit USD 1715.8 Million in 2028, Says Brandessence Market Research
Published: 2022-03-14 (Crawled : 12:00) - prnewswire.com
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
PHG | News | $20.97 -0.19% 0.0% 650K
|
Health Technology
|
| O: -1.67%
H: 0.0%
C: 0.0%
GE | News | $159.19 -2.11% 0.0% 10M
|
Electronic Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
CNMD | $70.01 -1.82% -3.0% 1.2M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
BSX | $72.91 5.68% -0.03% 15M
|
Health Technology
|
| O: 0.31%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -2.3%
H: 0.0%
C: 0.0%
MMM | $92.02 -1.05% 0.0% 3.8M
|
Producer Manufacturing
|
| O: -1.29%
H: 0.0%
C: 0.0%
NTUS | $32.96 0.09% 0.0%
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: 0.0%
CNMD | $70.01 -1.82% -3.0% 1.2M
|
Health Technology
|
| O: -0.86%
H: 0.0%
C: 0.0%
ce mark research
Global Endoscopy Device Market (2021 to 2026) - Featuring Arthrex, Conmed and Olympus Among Others
Published: 2021-08-27 (Crawled : 22:00) - prnewswire.com
BSX | $72.91 5.68% -0.03% 15M
|
Health Technology
| Email alert
Add to watchlist
CNMD | $70.01 -1.82% -3.0% 1.2M
|
Health Technology
| Email alert
Add to watchlist
CNMD | $70.01 -1.82% -3.0% 1.2M
|
Health Technology
| Email alert
Add to watchlist
endoscopy ce mark device
Boston Scientific Completes CE Mark for EXALT™ Model B Single-Use Bronchoscope
Published: 2021-05-25 (Crawled : 12:00) - biospace.com/
BSX | $72.91 5.68% -0.03% 15M
|
Health Technology
|
| O: 0.49%
H: 0.77%
C: 0.05%
ce mark
Surge in Demand for Lithotripsy for Non-invasiveness, Low Risk of Failure Creates Opportunities in Lithotripsy Device Market, Innovations of Laser-based Products to Expand Growth Vistas, TMR
Published: 2021-05-19 (Crawled : 16:00) - prnewswire.com
BSX | $72.91 5.68% -0.03% 15M
|
Health Technology
|
| O: -1.22%
H: 0.57%
C: 0.41%
laser risk ce mark growth device
Pharmaceutical and Life Sciences Real World Evidence Market Outlook 2021-2030: Comparison of Randomized Clinical Trials and Real World Evidence
Published: 2021-05-04 (Crawled : 18:00) - prnewswire.com
BSX | $72.91 5.68% -0.03% 15M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: -0.39%
clinical trials ce mark life science trial
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.